Prolonged Gut Dysbiosis and Fecal Excretion of Hepatitis A Virus in Patients Infected with Human Immunodeficiency Virus.
Aya IshizakaMichiko KogaTaketoshi MizutaniLay Ahyoung LimEisuke AdachiKazuhiko IkeuchiRyuta UedaHaruyo AoyagiSatoshi TanakaHiroshi KiyonoTetsuro MatanoHideki AizakiSachiyo YoshioEiji MitaMasamichi MuramatsuTatsuya KantoTakeya TsutsumiHiroshi YotsuyanagiPublished in: Viruses (2021)
Hepatitis A virus (HAV) causes transient acute infection, and little is known of viral shedding via the duodenum and into the intestinal environment, including the gut microbiome, from the period of infection until after the recovery of symptoms. Therefore, in this study, we aimed to comprehensively observe the amount of virus excreted into the intestinal tract, the changes in the intestinal microbiome, and the level of inflammation during the healing process. We used blood and stool specimens from patients with human immunodeficiency virus who were infected with HAV during the HAV outbreak in Japan in 2018. Moreover, we observed changes in fecal HAV RNA and quantified the plasma cytokine level and gut microbiome by 16S rRNA analysis from clinical onset to at least 6 months after healing. HAV was detected from clinical onset up to a period of more than 150 days. Immediately after infection, many pro-inflammatory cytokines were elicited, and some cytokines showed different behaviors. The intestinal microbiome changed significantly after infection (dysbiosis), and the dysbiosis continued for a long time after healing. These observations suggest that the immunocompromised state is associated with prolonged viral shedding into the intestinal tract and delayed recovery of the intestinal environment.
Keyphrases
- human immunodeficiency virus
- hepatitis c virus
- antiretroviral therapy
- end stage renal disease
- hiv infected
- sars cov
- oxidative stress
- hiv positive
- newly diagnosed
- chronic kidney disease
- ejection fraction
- hiv aids
- peritoneal dialysis
- liver failure
- depressive symptoms
- respiratory failure
- intensive care unit
- patient reported outcomes
- blood brain barrier